These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 393515)
41. Biologic response modifiers as adjuncts to other therapeutic modalities. Borden EC; Hawkins MJ Semin Oncol; 1986 Jun; 13(2):144-52. PubMed ID: 2424086 [No Abstract] [Full Text] [Related]
42. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system. Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620 [TBL] [Abstract][Full Text] [Related]
43. DTIC (NSC-45388) in malignant melanoma: a perspective. Comis RL Cancer Treat Rep; 1976 Feb; 60(2):165-76. PubMed ID: 769969 [No Abstract] [Full Text] [Related]
44. [BCG therapy. Its role in the treatment of tumors of the bladder]. Patard JJ; Chopin DK; Abbou CC Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911 [No Abstract] [Full Text] [Related]
45. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity. Olsson L; Ebbesen P J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705 [TBL] [Abstract][Full Text] [Related]
52. Editorial: Large-bowel cancer-The current status of treatment. Carter SK J Natl Cancer Inst; 1976 Jan; 56(1):3-10. PubMed ID: 1255749 [No Abstract] [Full Text] [Related]
53. Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation. Pouillart R; Huong TH; Brugerie E; Lheritier J Biomedicine; 1974 Dec; 21(12):471-9. PubMed ID: 4462870 [No Abstract] [Full Text] [Related]
54. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
55. Effects of BCG on peripheral blood counts and drug tolerance of patients with non-Hodgkin lymphoma receiving combination chemotherapy. Brooks RJ; Jones SE; Gaines JA Med Pediatr Oncol; 1978; 5(1):1-7. PubMed ID: 85250 [No Abstract] [Full Text] [Related]
57. [Adjuvant therapy of bronchial carcinoma with special attention to immunotherapy]. Drings P Aktuelle Probl Chir Orthop; 1982; 22():30-5. PubMed ID: 6121510 [No Abstract] [Full Text] [Related]
58. An overview of the status of the nitrosoureas in other tumors. Carter SK Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034 [No Abstract] [Full Text] [Related]
59. Influence of age of host on the chemotherapy of murine myeloma LCP-1. Teller MN; Bowie M; Mountain IM J Gerontol; 1974 Jul; 29(4):360-5. PubMed ID: 4833754 [No Abstract] [Full Text] [Related]